Global Inactivated Polio Vaccine Market Research Report 2023
Polio vaccines can be classified into two types: the inactivated polio vaccine (IPV) and oral polio vaccine. Oral polio vaccine is more active than IPV as it has both weakened and live poliovirus. Inactivated polio vaccine is a vaccine prepared from suspension of inactivated (killed) poliovirus strains with formalin. It is an injectable vaccine that can either be given alone or with other vaccines. IPV has the ability to provide serum immunity against all the three types of poliovirus and consequent protection against paralytic poliomyelitis. The oral polio vaccine has the risk of transmission through human waste, causing the regulatory bodies to shift their demand towards IPV. Inactivated polio vaccines (IPV) have now been introduced into all countries’ routine immunization programmes, which are strengthening the fight to eradicate wild poliovirus (WPV).
According to QYResearch’s new survey, global Inactivated Polio Vaccine market is projected to reach US$ 926.8 million in 2029, increasing from US$ 688.5 million in 2022, with the CAGR of 4.4% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Inactivated Polio Vaccine market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Inactivated Polio Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
According to QYResearch’s new survey, global Inactivated Polio Vaccine market is projected to reach US$ 926.8 million in 2029, increasing from US$ 688.5 million in 2022, with the CAGR of 4.4% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Inactivated Polio Vaccine market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Inactivated Polio Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- Sanofi
- GSK
- Bibcol
- Serum Institute
- Tiantan Biological
- Panacea Biotec
- Bio-Med
- Halfkin Bio-Pharmaceuticals
- Government
- Private Sector
- Pediatrics
- Adults
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
1 INACTIVATED POLIO VACCINE MARKET OVERVIEW
1.1 Product Overview and Scope of Inactivated Polio Vaccine
1.2 Inactivated Polio Vaccine Segment by Type
1.2.1 Global Inactivated Polio Vaccine Market Value Comparison by Type (2023-2029)
1.2.2 Government
1.2.3 Private Sector
1.3 Inactivated Polio Vaccine Segment by Application
1.3.1 Global Inactivated Polio Vaccine Market Value by Application: (2023-2029)
1.3.2 Pediatrics
1.3.3 Adults
1.4 Global Inactivated Polio Vaccine Market Size Estimates and Forecasts
1.4.1 Global Inactivated Polio Vaccine Revenue 2018-2029
1.4.2 Global Inactivated Polio Vaccine Sales 2018-2029
1.4.3 Global Inactivated Polio Vaccine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 INACTIVATED POLIO VACCINE MARKET COMPETITION BY MANUFACTURERS
2.1 Global Inactivated Polio Vaccine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Inactivated Polio Vaccine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Inactivated Polio Vaccine Average Price by Manufacturers (2018-2023)
2.4 Global Inactivated Polio Vaccine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Inactivated Polio Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Inactivated Polio Vaccine, Product Type & Application
2.7 Inactivated Polio Vaccine Market Competitive Situation and Trends
2.7.1 Inactivated Polio Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Inactivated Polio Vaccine Players Market Share by Revenue
2.7.3 Global Inactivated Polio Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 INACTIVATED POLIO VACCINE RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Inactivated Polio Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Inactivated Polio Vaccine Global Inactivated Polio Vaccine Sales by Region: 2018-2029
3.2.1 Global Inactivated Polio Vaccine Sales by Region: 2018-2023
3.2.2 Global Inactivated Polio Vaccine Sales by Region: 2024-2029
3.3 Global Inactivated Polio Vaccine Global Inactivated Polio Vaccine Revenue by Region: 2018-2029
3.3.1 Global Inactivated Polio Vaccine Revenue by Region: 2018-2023
3.3.2 Global Inactivated Polio Vaccine Revenue by Region: 2024-2029
3.4 North America Inactivated Polio Vaccine Market Facts & Figures by Country
3.4.1 North America Inactivated Polio Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Inactivated Polio Vaccine Sales by Country (2018-2029)
3.4.3 North America Inactivated Polio Vaccine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Inactivated Polio Vaccine Market Facts & Figures by Country
3.5.1 Europe Inactivated Polio Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Inactivated Polio Vaccine Sales by Country (2018-2029)
3.5.3 Europe Inactivated Polio Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Inactivated Polio Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Inactivated Polio Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Inactivated Polio Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific Inactivated Polio Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Inactivated Polio Vaccine Market Facts & Figures by Country
3.7.1 Latin America Inactivated Polio Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Inactivated Polio Vaccine Sales by Country (2018-2029)
3.7.3 Latin America Inactivated Polio Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Inactivated Polio Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Inactivated Polio Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Inactivated Polio Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Inactivated Polio Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Inactivated Polio Vaccine Sales by Type (2018-2029)
4.1.1 Global Inactivated Polio Vaccine Sales by Type (2018-2023)
4.1.2 Global Inactivated Polio Vaccine Sales by Type (2024-2029)
4.1.3 Global Inactivated Polio Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Inactivated Polio Vaccine Revenue by Type (2018-2029)
4.2.1 Global Inactivated Polio Vaccine Revenue by Type (2018-2023)
4.2.2 Global Inactivated Polio Vaccine Revenue by Type (2024-2029)
4.2.3 Global Inactivated Polio Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Inactivated Polio Vaccine Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Inactivated Polio Vaccine Sales by Application (2018-2029)
5.1.1 Global Inactivated Polio Vaccine Sales by Application (2018-2023)
5.1.2 Global Inactivated Polio Vaccine Sales by Application (2024-2029)
5.1.3 Global Inactivated Polio Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Inactivated Polio Vaccine Revenue by Application (2018-2029)
5.2.1 Global Inactivated Polio Vaccine Revenue by Application (2018-2023)
5.2.2 Global Inactivated Polio Vaccine Revenue by Application (2024-2029)
5.2.3 Global Inactivated Polio Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Inactivated Polio Vaccine Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Inactivated Polio Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Sanofi Inactivated Polio Vaccine Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Inactivated Polio Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 GSK Inactivated Polio Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Bibcol
6.3.1 Bibcol Corporation Information
6.3.2 Bibcol Description and Business Overview
6.3.3 Bibcol Inactivated Polio Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Bibcol Inactivated Polio Vaccine Product Portfolio
6.3.5 Bibcol Recent Developments/Updates
6.4 Serum Institute
6.4.1 Serum Institute Corporation Information
6.4.2 Serum Institute Description and Business Overview
6.4.3 Serum Institute Inactivated Polio Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Serum Institute Inactivated Polio Vaccine Product Portfolio
6.4.5 Serum Institute Recent Developments/Updates
6.5 Tiantan Biological
6.5.1 Tiantan Biological Corporation Information
6.5.2 Tiantan Biological Description and Business Overview
6.5.3 Tiantan Biological Inactivated Polio Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Tiantan Biological Inactivated Polio Vaccine Product Portfolio
6.5.5 Tiantan Biological Recent Developments/Updates
6.6 Panacea Biotec
6.6.1 Panacea Biotec Corporation Information
6.6.2 Panacea Biotec Description and Business Overview
6.6.3 Panacea Biotec Inactivated Polio Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Panacea Biotec Inactivated Polio Vaccine Product Portfolio
6.6.5 Panacea Biotec Recent Developments/Updates
6.7 Bio-Med
6.6.1 Bio-Med Corporation Information
6.6.2 Bio-Med Description and Business Overview
6.6.3 Bio-Med Inactivated Polio Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Bio-Med Inactivated Polio Vaccine Product Portfolio
6.7.5 Bio-Med Recent Developments/Updates
6.8 Halfkin Bio-Pharmaceuticals
6.8.1 Halfkin Bio-Pharmaceuticals Corporation Information
6.8.2 Halfkin Bio-Pharmaceuticals Description and Business Overview
6.8.3 Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Product Portfolio
6.8.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Inactivated Polio Vaccine Industry Chain Analysis
7.2 Inactivated Polio Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Inactivated Polio Vaccine Production Mode & Process
7.4 Inactivated Polio Vaccine Sales and Marketing
7.4.1 Inactivated Polio Vaccine Sales Channels
7.4.2 Inactivated Polio Vaccine Distributors
7.5 Inactivated Polio Vaccine Customers
8 INACTIVATED POLIO VACCINE MARKET DYNAMICS
8.1 Inactivated Polio Vaccine Industry Trends
8.2 Inactivated Polio Vaccine Market Drivers
8.3 Inactivated Polio Vaccine Market Challenges
8.4 Inactivated Polio Vaccine Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Inactivated Polio Vaccine
1.2 Inactivated Polio Vaccine Segment by Type
1.2.1 Global Inactivated Polio Vaccine Market Value Comparison by Type (2023-2029)
1.2.2 Government
1.2.3 Private Sector
1.3 Inactivated Polio Vaccine Segment by Application
1.3.1 Global Inactivated Polio Vaccine Market Value by Application: (2023-2029)
1.3.2 Pediatrics
1.3.3 Adults
1.4 Global Inactivated Polio Vaccine Market Size Estimates and Forecasts
1.4.1 Global Inactivated Polio Vaccine Revenue 2018-2029
1.4.2 Global Inactivated Polio Vaccine Sales 2018-2029
1.4.3 Global Inactivated Polio Vaccine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 INACTIVATED POLIO VACCINE MARKET COMPETITION BY MANUFACTURERS
2.1 Global Inactivated Polio Vaccine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Inactivated Polio Vaccine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Inactivated Polio Vaccine Average Price by Manufacturers (2018-2023)
2.4 Global Inactivated Polio Vaccine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Inactivated Polio Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Inactivated Polio Vaccine, Product Type & Application
2.7 Inactivated Polio Vaccine Market Competitive Situation and Trends
2.7.1 Inactivated Polio Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Inactivated Polio Vaccine Players Market Share by Revenue
2.7.3 Global Inactivated Polio Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 INACTIVATED POLIO VACCINE RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Inactivated Polio Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Inactivated Polio Vaccine Global Inactivated Polio Vaccine Sales by Region: 2018-2029
3.2.1 Global Inactivated Polio Vaccine Sales by Region: 2018-2023
3.2.2 Global Inactivated Polio Vaccine Sales by Region: 2024-2029
3.3 Global Inactivated Polio Vaccine Global Inactivated Polio Vaccine Revenue by Region: 2018-2029
3.3.1 Global Inactivated Polio Vaccine Revenue by Region: 2018-2023
3.3.2 Global Inactivated Polio Vaccine Revenue by Region: 2024-2029
3.4 North America Inactivated Polio Vaccine Market Facts & Figures by Country
3.4.1 North America Inactivated Polio Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Inactivated Polio Vaccine Sales by Country (2018-2029)
3.4.3 North America Inactivated Polio Vaccine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Inactivated Polio Vaccine Market Facts & Figures by Country
3.5.1 Europe Inactivated Polio Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Inactivated Polio Vaccine Sales by Country (2018-2029)
3.5.3 Europe Inactivated Polio Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Inactivated Polio Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Inactivated Polio Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Inactivated Polio Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific Inactivated Polio Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Inactivated Polio Vaccine Market Facts & Figures by Country
3.7.1 Latin America Inactivated Polio Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Inactivated Polio Vaccine Sales by Country (2018-2029)
3.7.3 Latin America Inactivated Polio Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Inactivated Polio Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Inactivated Polio Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Inactivated Polio Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Inactivated Polio Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Inactivated Polio Vaccine Sales by Type (2018-2029)
4.1.1 Global Inactivated Polio Vaccine Sales by Type (2018-2023)
4.1.2 Global Inactivated Polio Vaccine Sales by Type (2024-2029)
4.1.3 Global Inactivated Polio Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Inactivated Polio Vaccine Revenue by Type (2018-2029)
4.2.1 Global Inactivated Polio Vaccine Revenue by Type (2018-2023)
4.2.2 Global Inactivated Polio Vaccine Revenue by Type (2024-2029)
4.2.3 Global Inactivated Polio Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Inactivated Polio Vaccine Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Inactivated Polio Vaccine Sales by Application (2018-2029)
5.1.1 Global Inactivated Polio Vaccine Sales by Application (2018-2023)
5.1.2 Global Inactivated Polio Vaccine Sales by Application (2024-2029)
5.1.3 Global Inactivated Polio Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Inactivated Polio Vaccine Revenue by Application (2018-2029)
5.2.1 Global Inactivated Polio Vaccine Revenue by Application (2018-2023)
5.2.2 Global Inactivated Polio Vaccine Revenue by Application (2024-2029)
5.2.3 Global Inactivated Polio Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Inactivated Polio Vaccine Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Inactivated Polio Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Sanofi Inactivated Polio Vaccine Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Inactivated Polio Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 GSK Inactivated Polio Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Bibcol
6.3.1 Bibcol Corporation Information
6.3.2 Bibcol Description and Business Overview
6.3.3 Bibcol Inactivated Polio Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Bibcol Inactivated Polio Vaccine Product Portfolio
6.3.5 Bibcol Recent Developments/Updates
6.4 Serum Institute
6.4.1 Serum Institute Corporation Information
6.4.2 Serum Institute Description and Business Overview
6.4.3 Serum Institute Inactivated Polio Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Serum Institute Inactivated Polio Vaccine Product Portfolio
6.4.5 Serum Institute Recent Developments/Updates
6.5 Tiantan Biological
6.5.1 Tiantan Biological Corporation Information
6.5.2 Tiantan Biological Description and Business Overview
6.5.3 Tiantan Biological Inactivated Polio Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Tiantan Biological Inactivated Polio Vaccine Product Portfolio
6.5.5 Tiantan Biological Recent Developments/Updates
6.6 Panacea Biotec
6.6.1 Panacea Biotec Corporation Information
6.6.2 Panacea Biotec Description and Business Overview
6.6.3 Panacea Biotec Inactivated Polio Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Panacea Biotec Inactivated Polio Vaccine Product Portfolio
6.6.5 Panacea Biotec Recent Developments/Updates
6.7 Bio-Med
6.6.1 Bio-Med Corporation Information
6.6.2 Bio-Med Description and Business Overview
6.6.3 Bio-Med Inactivated Polio Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Bio-Med Inactivated Polio Vaccine Product Portfolio
6.7.5 Bio-Med Recent Developments/Updates
6.8 Halfkin Bio-Pharmaceuticals
6.8.1 Halfkin Bio-Pharmaceuticals Corporation Information
6.8.2 Halfkin Bio-Pharmaceuticals Description and Business Overview
6.8.3 Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Product Portfolio
6.8.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Inactivated Polio Vaccine Industry Chain Analysis
7.2 Inactivated Polio Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Inactivated Polio Vaccine Production Mode & Process
7.4 Inactivated Polio Vaccine Sales and Marketing
7.4.1 Inactivated Polio Vaccine Sales Channels
7.4.2 Inactivated Polio Vaccine Distributors
7.5 Inactivated Polio Vaccine Customers
8 INACTIVATED POLIO VACCINE MARKET DYNAMICS
8.1 Inactivated Polio Vaccine Industry Trends
8.2 Inactivated Polio Vaccine Market Drivers
8.3 Inactivated Polio Vaccine Market Challenges
8.4 Inactivated Polio Vaccine Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
LIST OF TABLES
Table 1. Global Inactivated Polio Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Inactivated Polio Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Inactivated Polio Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Inactivated Polio Vaccine Sales (K Dose) of Key Manufacturers (2018-2023)
Table 5. Global Inactivated Polio Vaccine Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Inactivated Polio Vaccine Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Inactivated Polio Vaccine Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Inactivated Polio Vaccine Average Price (US$/Dose) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Inactivated Polio Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Inactivated Polio Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Inactivated Polio Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Inactivated Polio Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Inactivated Polio Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Polio Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Inactivated Polio Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Inactivated Polio Vaccine Sales by Region (2018-2023) & (K Dose)
Table 18. Global Inactivated Polio Vaccine Sales Market Share by Region (2018-2023)
Table 19. Global Inactivated Polio Vaccine Sales by Region (2024-2029) & (K Dose)
Table 20. Global Inactivated Polio Vaccine Sales Market Share by Region (2024-2029)
Table 21. Global Inactivated Polio Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Inactivated Polio Vaccine Revenue Market Share by Region (2018-2023)
Table 23. Global Inactivated Polio Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Inactivated Polio Vaccine Revenue Market Share by Region (2024-2029)
Table 25. North America Inactivated Polio Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Inactivated Polio Vaccine Sales by Country (2018-2023) & (K Dose)
Table 27. North America Inactivated Polio Vaccine Sales by Country (2024-2029) & (K Dose)
Table 28. North America Inactivated Polio Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Inactivated Polio Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Inactivated Polio Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Inactivated Polio Vaccine Sales by Country (2018-2023) & (K Dose)
Table 32. Europe Inactivated Polio Vaccine Sales by Country (2024-2029) & (K Dose)
Table 33. Europe Inactivated Polio Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Inactivated Polio Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Inactivated Polio Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Inactivated Polio Vaccine Sales by Region (2018-2023) & (K Dose)
Table 37. Asia Pacific Inactivated Polio Vaccine Sales by Region (2024-2029) & (K Dose)
Table 38. Asia Pacific Inactivated Polio Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Inactivated Polio Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Inactivated Polio Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Inactivated Polio Vaccine Sales by Country (2018-2023) & (K Dose)
Table 42. Latin America Inactivated Polio Vaccine Sales by Country (2024-2029) & (K Dose)
Table 43. Latin America Inactivated Polio Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Inactivated Polio Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Inactivated Polio Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Inactivated Polio Vaccine Sales by Country (2018-2023) & (K Dose)
Table 47. Middle East & Africa Inactivated Polio Vaccine Sales by Country (2024-2029) & (K Dose)
Table 48. Middle East & Africa Inactivated Polio Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Inactivated Polio Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Inactivated Polio Vaccine Sales (K Dose) by Type (2018-2023)
Table 51. Global Inactivated Polio Vaccine Sales (K Dose) by Type (2024-2029)
Table 52. Global Inactivated Polio Vaccine Sales Market Share by Type (2018-2023)
Table 53. Global Inactivated Polio Vaccine Sales Market Share by Type (2024-2029)
Table 54. Global Inactivated Polio Vaccine Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Inactivated Polio Vaccine Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Inactivated Polio Vaccine Revenue Market Share by Type (2018-2023)
Table 57. Global Inactivated Polio Vaccine Revenue Market Share by Type (2024-2029)
Table 58. Global Inactivated Polio Vaccine Price (US$/Dose) by Type (2018-2023)
Table 59. Global Inactivated Polio Vaccine Price (US$/Dose) by Type (2024-2029)
Table 60. Global Inactivated Polio Vaccine Sales (K Dose) by Application (2018-2023)
Table 61. Global Inactivated Polio Vaccine Sales (K Dose) by Application (2024-2029)
Table 62. Global Inactivated Polio Vaccine Sales Market Share by Application (2018-2023)
Table 63. Global Inactivated Polio Vaccine Sales Market Share by Application (2024-2029)
Table 64. Global Inactivated Polio Vaccine Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Inactivated Polio Vaccine Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Inactivated Polio Vaccine Revenue Market Share by Application (2018-2023)
Table 67. Global Inactivated Polio Vaccine Revenue Market Share by Application (2024-2029)
Table 68. Global Inactivated Polio Vaccine Price (US$/Dose) by Application (2018-2023)
Table 69. Global Inactivated Polio Vaccine Price (US$/Dose) by Application (2024-2029)
Table 70. Sanofi Corporation Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi Inactivated Polio Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 73. Sanofi Inactivated Polio Vaccine Product
Table 74. Sanofi Recent Developments/Updates
Table 75. GSK Corporation Information
Table 76. GSK Description and Business Overview
Table 77. GSK Inactivated Polio Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 78. GSK Inactivated Polio Vaccine Product
Table 79. GSK Recent Developments/Updates
Table 80. Bibcol Corporation Information
Table 81. Bibcol Description and Business Overview
Table 82. Bibcol Inactivated Polio Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 83. Bibcol Inactivated Polio Vaccine Product
Table 84. Bibcol Recent Developments/Updates
Table 85. Serum Institute Corporation Information
Table 86. Serum Institute Description and Business Overview
Table 87. Serum Institute Inactivated Polio Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 88. Serum Institute Inactivated Polio Vaccine Product
Table 89. Serum Institute Recent Developments/Updates
Table 90. Tiantan Biological Corporation Information
Table 91. Tiantan Biological Description and Business Overview
Table 92. Tiantan Biological Inactivated Polio Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 93. Tiantan Biological Inactivated Polio Vaccine Product
Table 94. Tiantan Biological Recent Developments/Updates
Table 95. Panacea Biotec Corporation Information
Table 96. Panacea Biotec Description and Business Overview
Table 97. Panacea Biotec Inactivated Polio Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 98. Panacea Biotec Inactivated Polio Vaccine Product
Table 99. Panacea Biotec Recent Developments/Updates
Table 100. Bio-Med Corporation Information
Table 101. Bio-Med Description and Business Overview
Table 102. Bio-Med Inactivated Polio Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 103. Bio-Med Inactivated Polio Vaccine Product
Table 104. Bio-Med Recent Developments/Updates
Table 105. Halfkin Bio-Pharmaceuticals Corporation Information
Table 106. Halfkin Bio-Pharmaceuticals Description and Business Overview
Table 107. Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 108. Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Product
Table 109. Halfkin Bio-Pharmaceuticals Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Inactivated Polio Vaccine Distributors List
Table 113. Inactivated Polio Vaccine Customers List
Table 114. Inactivated Polio Vaccine Market Trends
Table 115. Inactivated Polio Vaccine Market Drivers
Table 116. Inactivated Polio Vaccine Market Challenges
Table 117. Inactivated Polio Vaccine Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 1. Global Inactivated Polio Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Inactivated Polio Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Inactivated Polio Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Inactivated Polio Vaccine Sales (K Dose) of Key Manufacturers (2018-2023)
Table 5. Global Inactivated Polio Vaccine Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Inactivated Polio Vaccine Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Inactivated Polio Vaccine Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Inactivated Polio Vaccine Average Price (US$/Dose) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Inactivated Polio Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Inactivated Polio Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Inactivated Polio Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Inactivated Polio Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Inactivated Polio Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Polio Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Inactivated Polio Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Inactivated Polio Vaccine Sales by Region (2018-2023) & (K Dose)
Table 18. Global Inactivated Polio Vaccine Sales Market Share by Region (2018-2023)
Table 19. Global Inactivated Polio Vaccine Sales by Region (2024-2029) & (K Dose)
Table 20. Global Inactivated Polio Vaccine Sales Market Share by Region (2024-2029)
Table 21. Global Inactivated Polio Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Inactivated Polio Vaccine Revenue Market Share by Region (2018-2023)
Table 23. Global Inactivated Polio Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Inactivated Polio Vaccine Revenue Market Share by Region (2024-2029)
Table 25. North America Inactivated Polio Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Inactivated Polio Vaccine Sales by Country (2018-2023) & (K Dose)
Table 27. North America Inactivated Polio Vaccine Sales by Country (2024-2029) & (K Dose)
Table 28. North America Inactivated Polio Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Inactivated Polio Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Inactivated Polio Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Inactivated Polio Vaccine Sales by Country (2018-2023) & (K Dose)
Table 32. Europe Inactivated Polio Vaccine Sales by Country (2024-2029) & (K Dose)
Table 33. Europe Inactivated Polio Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Inactivated Polio Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Inactivated Polio Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Inactivated Polio Vaccine Sales by Region (2018-2023) & (K Dose)
Table 37. Asia Pacific Inactivated Polio Vaccine Sales by Region (2024-2029) & (K Dose)
Table 38. Asia Pacific Inactivated Polio Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Inactivated Polio Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Inactivated Polio Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Inactivated Polio Vaccine Sales by Country (2018-2023) & (K Dose)
Table 42. Latin America Inactivated Polio Vaccine Sales by Country (2024-2029) & (K Dose)
Table 43. Latin America Inactivated Polio Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Inactivated Polio Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Inactivated Polio Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Inactivated Polio Vaccine Sales by Country (2018-2023) & (K Dose)
Table 47. Middle East & Africa Inactivated Polio Vaccine Sales by Country (2024-2029) & (K Dose)
Table 48. Middle East & Africa Inactivated Polio Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Inactivated Polio Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Inactivated Polio Vaccine Sales (K Dose) by Type (2018-2023)
Table 51. Global Inactivated Polio Vaccine Sales (K Dose) by Type (2024-2029)
Table 52. Global Inactivated Polio Vaccine Sales Market Share by Type (2018-2023)
Table 53. Global Inactivated Polio Vaccine Sales Market Share by Type (2024-2029)
Table 54. Global Inactivated Polio Vaccine Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Inactivated Polio Vaccine Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Inactivated Polio Vaccine Revenue Market Share by Type (2018-2023)
Table 57. Global Inactivated Polio Vaccine Revenue Market Share by Type (2024-2029)
Table 58. Global Inactivated Polio Vaccine Price (US$/Dose) by Type (2018-2023)
Table 59. Global Inactivated Polio Vaccine Price (US$/Dose) by Type (2024-2029)
Table 60. Global Inactivated Polio Vaccine Sales (K Dose) by Application (2018-2023)
Table 61. Global Inactivated Polio Vaccine Sales (K Dose) by Application (2024-2029)
Table 62. Global Inactivated Polio Vaccine Sales Market Share by Application (2018-2023)
Table 63. Global Inactivated Polio Vaccine Sales Market Share by Application (2024-2029)
Table 64. Global Inactivated Polio Vaccine Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Inactivated Polio Vaccine Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Inactivated Polio Vaccine Revenue Market Share by Application (2018-2023)
Table 67. Global Inactivated Polio Vaccine Revenue Market Share by Application (2024-2029)
Table 68. Global Inactivated Polio Vaccine Price (US$/Dose) by Application (2018-2023)
Table 69. Global Inactivated Polio Vaccine Price (US$/Dose) by Application (2024-2029)
Table 70. Sanofi Corporation Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi Inactivated Polio Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 73. Sanofi Inactivated Polio Vaccine Product
Table 74. Sanofi Recent Developments/Updates
Table 75. GSK Corporation Information
Table 76. GSK Description and Business Overview
Table 77. GSK Inactivated Polio Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 78. GSK Inactivated Polio Vaccine Product
Table 79. GSK Recent Developments/Updates
Table 80. Bibcol Corporation Information
Table 81. Bibcol Description and Business Overview
Table 82. Bibcol Inactivated Polio Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 83. Bibcol Inactivated Polio Vaccine Product
Table 84. Bibcol Recent Developments/Updates
Table 85. Serum Institute Corporation Information
Table 86. Serum Institute Description and Business Overview
Table 87. Serum Institute Inactivated Polio Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 88. Serum Institute Inactivated Polio Vaccine Product
Table 89. Serum Institute Recent Developments/Updates
Table 90. Tiantan Biological Corporation Information
Table 91. Tiantan Biological Description and Business Overview
Table 92. Tiantan Biological Inactivated Polio Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 93. Tiantan Biological Inactivated Polio Vaccine Product
Table 94. Tiantan Biological Recent Developments/Updates
Table 95. Panacea Biotec Corporation Information
Table 96. Panacea Biotec Description and Business Overview
Table 97. Panacea Biotec Inactivated Polio Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 98. Panacea Biotec Inactivated Polio Vaccine Product
Table 99. Panacea Biotec Recent Developments/Updates
Table 100. Bio-Med Corporation Information
Table 101. Bio-Med Description and Business Overview
Table 102. Bio-Med Inactivated Polio Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 103. Bio-Med Inactivated Polio Vaccine Product
Table 104. Bio-Med Recent Developments/Updates
Table 105. Halfkin Bio-Pharmaceuticals Corporation Information
Table 106. Halfkin Bio-Pharmaceuticals Description and Business Overview
Table 107. Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 108. Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Product
Table 109. Halfkin Bio-Pharmaceuticals Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Inactivated Polio Vaccine Distributors List
Table 113. Inactivated Polio Vaccine Customers List
Table 114. Inactivated Polio Vaccine Market Trends
Table 115. Inactivated Polio Vaccine Market Drivers
Table 116. Inactivated Polio Vaccine Market Challenges
Table 117. Inactivated Polio Vaccine Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Product Picture of Inactivated Polio Vaccine
Figure 2. Global Inactivated Polio Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Inactivated Polio Vaccine Market Share by Type in 2022 & 2029
Figure 4. Government Product Picture
Figure 5. Private Sector Product Picture
Figure 6. Global Inactivated Polio Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Inactivated Polio Vaccine Market Share by Application in 2022 & 2029
Figure 8. Pediatrics
Figure 9. Adults
Figure 10. Global Inactivated Polio Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Inactivated Polio Vaccine Market Size (2018-2029) & (US$ Million)
Figure 12. Global Inactivated Polio Vaccine Sales (2018-2029) & (K Dose)
Figure 13. Global Inactivated Polio Vaccine Average Price (US$/Dose) & (2018-2029)
Figure 14. Inactivated Polio Vaccine Report Years Considered
Figure 15. Inactivated Polio Vaccine Sales Share by Manufacturers in 2022
Figure 16. Global Inactivated Polio Vaccine Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Inactivated Polio Vaccine Players: Market Share by Revenue in 2022
Figure 18. Inactivated Polio Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Inactivated Polio Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Inactivated Polio Vaccine Sales Market Share by Country (2018-2029)
Figure 21. North America Inactivated Polio Vaccine Revenue Market Share by Country (2018-2029)
Figure 22. United States Inactivated Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Inactivated Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Inactivated Polio Vaccine Sales Market Share by Country (2018-2029)
Figure 25. Europe Inactivated Polio Vaccine Revenue Market Share by Country (2018-2029)
Figure 26. Germany Inactivated Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Inactivated Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Inactivated Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Inactivated Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Inactivated Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Inactivated Polio Vaccine Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Inactivated Polio Vaccine Revenue Market Share by Region (2018-2029)
Figure 33. China Inactivated Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Inactivated Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Inactivated Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Inactivated Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Inactivated Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Inactivated Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia Inactivated Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand Inactivated Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia Inactivated Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Inactivated Polio Vaccine Sales Market Share by Country (2018-2029)
Figure 43. Latin America Inactivated Polio Vaccine Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Inactivated Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Inactivated Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Inactivated Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Inactivated Polio Vaccine Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Inactivated Polio Vaccine Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Inactivated Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Inactivated Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Inactivated Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Inactivated Polio Vaccine by Type (2018-2029)
Figure 53. Global Revenue Market Share of Inactivated Polio Vaccine by Type (2018-2029)
Figure 54. Global Inactivated Polio Vaccine Price (US$/Dose) by Type (2018-2029)
Figure 55. Global Sales Market Share of Inactivated Polio Vaccine by Application (2018-2029)
Figure 56. Global Revenue Market Share of Inactivated Polio Vaccine by Application (2018-2029)
Figure 57. Global Inactivated Polio Vaccine Price (US$/Dose) by Application (2018-2029)
Figure 58. Inactivated Polio Vaccine Value Chain
Figure 59. Inactivated Polio Vaccine Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Figure 1. Product Picture of Inactivated Polio Vaccine
Figure 2. Global Inactivated Polio Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Inactivated Polio Vaccine Market Share by Type in 2022 & 2029
Figure 4. Government Product Picture
Figure 5. Private Sector Product Picture
Figure 6. Global Inactivated Polio Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Inactivated Polio Vaccine Market Share by Application in 2022 & 2029
Figure 8. Pediatrics
Figure 9. Adults
Figure 10. Global Inactivated Polio Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Inactivated Polio Vaccine Market Size (2018-2029) & (US$ Million)
Figure 12. Global Inactivated Polio Vaccine Sales (2018-2029) & (K Dose)
Figure 13. Global Inactivated Polio Vaccine Average Price (US$/Dose) & (2018-2029)
Figure 14. Inactivated Polio Vaccine Report Years Considered
Figure 15. Inactivated Polio Vaccine Sales Share by Manufacturers in 2022
Figure 16. Global Inactivated Polio Vaccine Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Inactivated Polio Vaccine Players: Market Share by Revenue in 2022
Figure 18. Inactivated Polio Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Inactivated Polio Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Inactivated Polio Vaccine Sales Market Share by Country (2018-2029)
Figure 21. North America Inactivated Polio Vaccine Revenue Market Share by Country (2018-2029)
Figure 22. United States Inactivated Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Inactivated Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Inactivated Polio Vaccine Sales Market Share by Country (2018-2029)
Figure 25. Europe Inactivated Polio Vaccine Revenue Market Share by Country (2018-2029)
Figure 26. Germany Inactivated Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Inactivated Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Inactivated Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Inactivated Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Inactivated Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Inactivated Polio Vaccine Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Inactivated Polio Vaccine Revenue Market Share by Region (2018-2029)
Figure 33. China Inactivated Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Inactivated Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Inactivated Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Inactivated Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Inactivated Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Inactivated Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia Inactivated Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand Inactivated Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia Inactivated Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Inactivated Polio Vaccine Sales Market Share by Country (2018-2029)
Figure 43. Latin America Inactivated Polio Vaccine Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Inactivated Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Inactivated Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Inactivated Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Inactivated Polio Vaccine Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Inactivated Polio Vaccine Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Inactivated Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Inactivated Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Inactivated Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Inactivated Polio Vaccine by Type (2018-2029)
Figure 53. Global Revenue Market Share of Inactivated Polio Vaccine by Type (2018-2029)
Figure 54. Global Inactivated Polio Vaccine Price (US$/Dose) by Type (2018-2029)
Figure 55. Global Sales Market Share of Inactivated Polio Vaccine by Application (2018-2029)
Figure 56. Global Revenue Market Share of Inactivated Polio Vaccine by Application (2018-2029)
Figure 57. Global Inactivated Polio Vaccine Price (US$/Dose) by Application (2018-2029)
Figure 58. Inactivated Polio Vaccine Value Chain
Figure 59. Inactivated Polio Vaccine Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
